Aron Kater


Research output per year

If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 11 Article
  • 2 Comment/Letter to the editor
  • 2 Review article
  • 1 Letter

Proteomic markers with prognostic impact on outcome of chronic lymphocytic leukemia patients under chemo-immunotherapy: results from the HOVON 109 study

Saberi Hosnijeh, F., van der Straten, L., Kater, A. P., van Oers, M. H. J., Posthuma, W. F. M., Chamuleau, M. E. D., Bellido, M., Doorduijn, J. K., van Gelder, M., Hoogendoorn, M., de Boer, F., te Raa, G. D., Kerst, J. M., Marijt, E. W. A., Raymakers, R. A. P., Koene, H. R., Schaafsma, M. R., Dobber, J. A., Tonino, S. H., Kersting, S. S. & 2 others, Langerak, A. W. & Levin, M-D., Sep 2020, In : Experimental Hematology. 89, p. 55-60.e6

Research output: Contribution to journalArticleAcademicpeer-review

Bayesian Population Model of the Pharmacokinetics of Venetoclax in Combination with Rituximab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: Results from the Phase III MURANO Study

Deng, R., Gibiansky, L., Lu, T., Agarwal, P., Ding, H., Li, X., Kshirsagar, S., Lu, D., Li, C., Girish, S., Wang, J., Boyer, M., Humphrey, K., Freise, K. J., Salem, A. H., Seymour, J. F., Kater, A. P. & Miles, D., 1 Dec 2019, In : Clinical Pharmacokinetics. 58, 12, p. 1621-1634 14 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Chronic lymphocytic leukemia cells impair mitochondrial fitness in CD8+ T cells and impede CAR T-cell efficacy

van Bruggen, J. A. C., Martens, A. W. J., Fraietta, J. A., Hofland, T., Tonino, S. H., Eldering, E., Levin, M-D., Siska, P. J., Endstra, S., Rathmell, J. C., June, C. H., Porter, D. L., Melenhorst, J. J., Kater, A. P. & van der Windt, G. J. W., 4 Jul 2019, In : Blood. 134, 1, p. 44-58

Research output: Contribution to journalArticleAcademicpeer-review

Cytogenetic complexity in chronic lymphocytic leukemia: Definitions, associations, and clinical impact

Baliakas, P., Jeromin, S., Iskas, M., Puiggros, A., Plevova, K., Nguyen-Khac, F., Davis, Z., Matteo Rigolin, G., Visentin, A., Xochelli, A., Delgado, J., Baran-Marszak, F., Stalika, E., Abrisqueta, P., Durechova, K., Papaioannou, G., Eclache, V., DImou, M., Iliakis, T., Collado, R. & 23 others, Doubek, M., Calasanz, M. J., Ruiz-Xiville, N., Moreno, C., Jarosova, M., Leeksma, A. C., Panayiotidis, P., Podgornik, H., Cymbalista, F., Anagnostopoulos, A., Trentin, L., Stavroyianni, N., Davi, F., Ghia, P., Kater, A. P., Cuneo, A., Pospisilova, S., Espinet, B., Athanasiadou, A., Oscier, D., Haferlach, C., Stamatopoulos, K. & on behalf of ERIC, the European Research Initiative on CLL, 1 Jan 2019, In : Blood. 133, 11, p. 1205-1216

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Dissection of the Effects of JAK and BTK Inhibitors on the Functionality of Healthy and Malignant Lymphocytes

Hofland, T., de Weerdt, I., ter Burg, H., de Boer, R., Tannheimer, S., Tonino, S. H., Kater, A. P. & Eldering, E., 15 Oct 2019, In : Journal of Immunology. 203, 8, p. 2100-2109

Research output: Contribution to journalArticleAcademicpeer-review